Sidewinder Therapeutics and Stipple Bio are advancing next-generation antibody drug conjugates for cancer, using bispecific targeting and tumor-specific epitopes.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Two New Takes on Making a Type of Targeted Cancer Therapy Even Better - MedCity News
$137 Million funding raised
$162 Million total funding to date
$100 Million funding raised by Stipple Bio